Standard vs delayed ligature of the dorsal vascular complex during robot-assisted radical prostatectomy: results from a randomized controlled trial.
Blood loss
Dorsal vascular complex
Positive surgical margins
Prostate cancer
Robot-assisted radical prostatectomy
Journal
Journal of robotic surgery
ISSN: 1863-2491
Titre abrégé: J Robot Surg
Pays: England
ID NLM: 101300401
Informations de publication
Date de publication:
Apr 2019
Apr 2019
Historique:
received:
21
05
2018
accepted:
09
07
2018
pubmed:
15
7
2018
medline:
11
7
2019
entrez:
15
7
2018
Statut:
ppublish
Résumé
Prospective randomized trial to compare standard vs delayed approach to dorsal vascular complex (s-DVC vs d-DVC) in robot-assisted radical prostatectomy (RARP). Patients scheduled for RARP were randomized into a 1:1 ratio to receive either s-DVC or d-DVC by two experienced surgeons. In s-DVC arm an eight-shaped single stitch was given at the beginning of the procedure and the DVC was subsequently cut at time of apical dissection; in d-DVC arm the plexus was transected at the end of prostatectomy, prior to apex dissection and then sutured. Primary endpoint was difference in estimated blood loss (EBL) and a sample size of 226 cases was calculated; ad interim analysis was planned after 2/3 of recruitment. Endpoint was reached at ad interim analysis after 162 cases (81 s-DVC, 81 d-DVC) and recruitment was, therefore, interrupted. Baseline and tumor characteristics were overlapping. EBL was significantly higher in d-DVC arm (mean EBL 107 vs 65 ml, p = 0.003), but without differences in post-operative hemoglobin, transfusions and complications. Overall PSM rate was higher in d-DVC arm (21.0 vs 14.8%, p = 0.323), with statistical significance relatively to organ-confined disease (15.5 vs 3.6%, p = 0.031). Apical involvement was instead significantly higher in s-DVC arm (prevalence in PSM patients 66.7 vs 23.5%, p = 0.020). Post-operative PSA, continence and potency rates were similar between groups. Standard and delayed approaches to DVC are safe and lead to similar functional outcomes. A delayed approach exposes to a higher risk of PSM in organ-confined disease but with a lower risk of apical involvement.
Identifiants
pubmed: 30006861
doi: 10.1007/s11701-018-0847-9
pii: 10.1007/s11701-018-0847-9
doi:
Types de publication
Clinical Trial, Phase III
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
253-260Références
Clin Perform Qual Health Care. 1993 Oct-Dec;1(4):219-22
pubmed: 10135639
Urology. 2000 Dec 20;56(6):899-905
pubmed: 11113727
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Eur Urol. 2009 Jun;55(6):1377-83
pubmed: 19243886
BJU Int. 2010 Aug;106(3):385-90
pubmed: 20067457
BMJ. 2010 Mar 23;340:c332
pubmed: 20332509
Eur Urol. 2011 Feb;59(2):235-43
pubmed: 20863611
Minerva Urol Nefrol. 2010 Sep;62(3):295-304
pubmed: 20940698
J Endourol. 2012 Dec;26(12):1605-8
pubmed: 22691123
Int J Urol. 2013 May;20(5):493-500
pubmed: 23039276
Can J Urol. 2013 Dec;20(6):7079-83
pubmed: 24331354
Urology. 2014 Dec;84(6):1453-8
pubmed: 25432837
Nihon Hinyokika Gakkai Zasshi. 2015 Jan;106(1):7-11
pubmed: 26399124
Am J Surg Pathol. 2016 Feb;40(2):244-52
pubmed: 26492179
Eur Urol. 2016 Aug;70(2):301-11
pubmed: 26850969
Eur Urol. 2016 Nov;70(5):837-845
pubmed: 26874806
World J Urol. 2017 Mar;35(3):395-402
pubmed: 27380209
Lancet. 2016 Sep 10;388(10049):1057-1066
pubmed: 27474375
Minerva Urol Nefrol. 2017 Feb;69(1):63-68
pubmed: 28009146
Eur Urol. 2017 Oct;72(4):632-640
pubmed: 28412062
Eur Urol Focus. 2018 Jul;4(4):608-613
pubmed: 28753862
BJU Int. 2018 Jun;121(6):845-853
pubmed: 29063728
Br J Cancer. 2018 Feb 20;118(4):489-494
pubmed: 29348490
NCI Monogr. 1988;(7):133-7
pubmed: 3173499
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
J Am Coll Surg. 1997 Oct;185(4):315-27
pubmed: 9328380